JPWO2019182109A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019182109A5
JPWO2019182109A5 JP2020507927A JP2020507927A JPWO2019182109A5 JP WO2019182109 A5 JPWO2019182109 A5 JP WO2019182109A5 JP 2020507927 A JP2020507927 A JP 2020507927A JP 2020507927 A JP2020507927 A JP 2020507927A JP WO2019182109 A5 JPWO2019182109 A5 JP WO2019182109A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid complex
unsubstituted
substituted
acid chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020507927A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019182109A1 (ja
JP7262816B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/012077 external-priority patent/WO2019182109A1/ja
Publication of JPWO2019182109A1 publication Critical patent/JPWO2019182109A1/ja
Publication of JPWO2019182109A5 publication Critical patent/JPWO2019182109A5/ja
Priority to JP2023061429A priority Critical patent/JP7669602B2/ja
Application granted granted Critical
Publication of JP7262816B2 publication Critical patent/JP7262816B2/ja
Priority to JP2024188699A priority patent/JP2025063018A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020507927A 2018-03-22 2019-03-22 ヘテロ核酸のbbb通過脂質リガンド Active JP7262816B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023061429A JP7669602B2 (ja) 2018-03-22 2023-04-05 ヘテロ核酸のbbb通過脂質リガンド
JP2024188699A JP2025063018A (ja) 2018-03-22 2024-10-28 ヘテロ核酸のbbb通過脂質リガンド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018055372 2018-03-22
JP2018055372 2018-03-22
PCT/JP2019/012077 WO2019182109A1 (ja) 2018-03-22 2019-03-22 ヘテロ核酸のbbb通過脂質リガンド

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023061429A Division JP7669602B2 (ja) 2018-03-22 2023-04-05 ヘテロ核酸のbbb通過脂質リガンド

Publications (3)

Publication Number Publication Date
JPWO2019182109A1 JPWO2019182109A1 (ja) 2021-03-11
JPWO2019182109A5 true JPWO2019182109A5 (cg-RX-API-DMAC7.html) 2022-03-24
JP7262816B2 JP7262816B2 (ja) 2023-04-24

Family

ID=67986528

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020507927A Active JP7262816B2 (ja) 2018-03-22 2019-03-22 ヘテロ核酸のbbb通過脂質リガンド
JP2023061429A Active JP7669602B2 (ja) 2018-03-22 2023-04-05 ヘテロ核酸のbbb通過脂質リガンド
JP2024188699A Pending JP2025063018A (ja) 2018-03-22 2024-10-28 ヘテロ核酸のbbb通過脂質リガンド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023061429A Active JP7669602B2 (ja) 2018-03-22 2023-04-05 ヘテロ核酸のbbb通過脂質リガンド
JP2024188699A Pending JP2025063018A (ja) 2018-03-22 2024-10-28 ヘテロ核酸のbbb通過脂質リガンド

Country Status (4)

Country Link
US (1) US20250333736A1 (cg-RX-API-DMAC7.html)
EP (1) EP3770257B1 (cg-RX-API-DMAC7.html)
JP (3) JP7262816B2 (cg-RX-API-DMAC7.html)
WO (1) WO2019182109A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3766972B1 (en) * 2018-03-14 2025-04-23 Institute of Science Tokyo Nucleic acid complex
JP7262816B2 (ja) * 2018-03-22 2023-04-24 国立大学法人 東京医科歯科大学 ヘテロ核酸のbbb通過脂質リガンド
WO2021054370A1 (ja) * 2019-09-18 2021-03-25 国立大学法人東京医科歯科大学 核酸複合体
AU2021382146A1 (en) 2020-11-23 2022-05-27 Alpha Anomeric Sas Nucleic acid duplexes
US20250179486A1 (en) * 2021-09-15 2025-06-05 National University Corporation Tokyo Medical And Dental University Heteronucleic acid including 2'-modified nucleoside
WO2024071099A1 (ja) 2022-09-29 2024-04-04 国立大学法人東京医科歯科大学 5'-シクロプロピレン修飾を含む核酸分子
GB202215614D0 (en) 2022-10-21 2022-12-07 Proqr Therapeutics Ii Bv Heteroduplex rna editing oligonucleotide complexes
CN118512601B (zh) * 2024-07-23 2024-12-10 深川生物科技(山东)股份公司 双链核酸-半乳糖胺-胆固醇化合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4912873B2 (ja) * 2003-04-09 2012-04-11 アルナイラム ファーマシューティカルズ, インコーポレイテッド iRNA複合体
EP2505646A1 (en) 2006-05-05 2012-10-03 Isis Pharmaceuticals, Inc. Compounds and methods for modulating expression of CRP
US20080039415A1 (en) * 2006-08-11 2008-02-14 Gregory Robert Stewart Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
EP2076597A2 (en) 2006-10-09 2009-07-08 Santaris Pharma A/S Rna antagonist compounds for the modulation of pcsk9
EP2410053B2 (en) 2006-10-18 2020-07-15 Ionis Pharmaceuticals, Inc. Antisense compounds
CN104126010B (zh) 2011-12-16 2021-04-06 国立大学法人东京医科齿科大学 嵌合的双链核酸
BR112015000236A2 (pt) 2012-07-10 2017-06-27 Baseclick Gmbh moléculas de ácidos nucleicos modificadas por anandamida
EP3353306A4 (en) 2015-09-25 2019-06-05 Ionis Pharmaceuticals, Inc. Conjugated antisense compounds and their use
US11433089B2 (en) * 2016-09-23 2022-09-06 National University Corporation Tokyo Medical And Dental University Blood-brain barrier permeable heteroduplex nucleic acid
JP6562515B2 (ja) 2016-09-28 2019-08-21 尾花 敏▲徳▼ セキュリティシステム
US11260134B2 (en) 2016-09-29 2022-03-01 National University Corporation Tokyo Medical And Dental University Double-stranded nucleic acid complex having overhang
JP7262816B2 (ja) * 2018-03-22 2023-04-24 国立大学法人 東京医科歯科大学 ヘテロ核酸のbbb通過脂質リガンド

Similar Documents

Publication Publication Date Title
JP7554488B2 (ja) 血液脳関門通過型ヘテロ2本鎖核酸
JP2023531311A5 (cg-RX-API-DMAC7.html)
JP7669602B2 (ja) ヘテロ核酸のbbb通過脂質リガンド
CN100400045C (zh) 基于核酸的化合物及其使用方法
JP2014520072A5 (cg-RX-API-DMAC7.html)
JP2021526823A5 (cg-RX-API-DMAC7.html)
JP2022506111A5 (cg-RX-API-DMAC7.html)
JP2008545793A5 (cg-RX-API-DMAC7.html)
CN1345242A (zh) 治疗白血病的方法
JP2013544245A5 (ja) ネプリライシンの発現および活性を増大させるための医薬組成物
JP2001511131A (ja) 月経前不快障害の処置
JP2022520986A5 (cg-RX-API-DMAC7.html)
JP2023528755A5 (cg-RX-API-DMAC7.html)
JP2022511568A5 (cg-RX-API-DMAC7.html)
JP7737667B2 (ja) 核酸複合体
JP2023528435A5 (cg-RX-API-DMAC7.html)
US20250223591A1 (en) Syf2 antisense oligonucleotides
WO2012147805A1 (ja) 脳移行性機能性核酸及びその利用
JP2004526706A5 (cg-RX-API-DMAC7.html)
JP2023532518A5 (cg-RX-API-DMAC7.html)
KR20080033322A (ko) 각성을 향상시키는 방법
JP2006510740A5 (cg-RX-API-DMAC7.html)
WO2024212954A1 (zh) 抑制lpa基因表达的化合物、药物组合物及其用途
JP2007500205A5 (cg-RX-API-DMAC7.html)
CN1533273A (zh) 紫杉烷类药物的节拍式给药